Evolus to Present at the Cantor Global Healthcare Conference
September 20 2018 - 4:01PM
Evolus, Inc. (NASDAQ:EOLS), a company dedicated to aesthetic
medicine, announced today that members of management will present
at the Cantor Global Healthcare Conference in New York, NY.
|
Event: |
Cantor Global
Healthcare Conference |
|
Date: |
Monday, October 1,
2018 |
|
Time: |
8:55 AM ET |
|
Location: |
Intercontinental New
York Barclay Hotel, New York, NY |
A live audio webcast of the event can be accessed on the Events
& Presentations page of the Investors section of Evolus’s
website at http://www.evolus.com, or by following the link
below in your web browser. An archived replay of the webcast will
be available on Evolus’s website for 30 days after the live event
concludes.
Webcast Link: http://wsw.com/webcast/cantor7/eols/
About Evolus, Inc.
Evolus is a company dedicated to aesthetic medicine focused on
providing physicians and their patients with expanded choices in
aesthetic treatments and procedures. Evolus’ lead candidate
DWP-450, also known by the chemical name prabotulinumtoxinA, is a
900 kDa purified botulinum toxin type A complex that was approved
by Health Canada for the temporary improvement in the appearance of
moderate to severe glabellar lines in adult patients under 65 years
of age and is being evaluated for marketing approval in the United
States and other areas.
Evolus Contacts:
Investor Contacts:Ashwin Agarwal, EvolusTel:
+1-949-284-4559Email: IR@Evolus.com
Brian Johnston, The Ruth Group Tel: +1
646-536-7028Email: IR@Evolus.com
Media Contact:Kirsten Thomas, The Ruth GroupTel:
+1-508-280-6592Email: kthomas@theruthgroup.com
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From Apr 2023 to Apr 2024